Veeva Systems Inc.

VEEV

US9224751084

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 16:00:02 2024-12-13 EST			5-day change	1st Jan Change
228.78 ^USD	-1.59%		-8.65%	+18.83%

12-11	Veeva Systems Inc. Presents at Raymond James 2024 TMT & Consumer Conference, Dec-11-2024 10:40 AM
12-06	Veeva Systems Insider Sold Shares Worth $390,128, According to a Recent SEC Filing	MT

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Veeva Systems Inc.

Veeva Systems Inc. Presents at Raymond James 2024 TMT & Consumer Conference, Dec-11-2024 10:40 AM	12-11
Veeva Systems Insider Sold Shares Worth $390,128, According to a Recent SEC Filing	12-06	MT
KeyBanc Raises Veeva Systems Price Target to $285 From $240, Maintains Overweight Rating	12-06	MT
Truist Securities Ups Price Target on Veeva Systems to $261 From $207, Keeps Hold Rating	12-06	MT
Will the strong economy be a brake on further rate cuts?	12-06
Sector Update: Health Care Stocks Edge Higher Premarket Friday	12-06	MT
Sector Update: Health Care	12-06	MT
UBS Raises Price Target on Veeva Systems to $250 From $245, Keeps Neutral Rating	12-06	MT
RBC Raises Price Target on Veeva Systems to $285 From $275, Keeps Outperform Rating	12-06	MT
Veeva Systems Fiscal Q3 Non-GAAP Earnings, Sales Rise; Lifts Full-Year Guidance; Shares Advance Premarket	12-06	MT
Analyst recommendations: Applovin, Delta Air Lines, Docusign, Salesforce, Halma...	12-06
Veeva Systems Inc., Q3 2025 Earnings Call, Dec 05, 2024	12-05
Veeva Systems Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Fiscal Year Outlook Raised	12-05	MT
Earnings Flash (VEEV) VEEVA SYSTEMS Posts Q3 Revenue $699.2M, vs. Street Est of $684.4M	12-05	MT
Earnings Flash (VEEV) VEEVA SYSTEMS Posts Q3 EPS $1.75, vs. Street Est of $1.58	12-05	MT
Veeva Systems Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2024	12-05	CI
Veeva Systems Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ending January 31, 2025	12-05	CI
Stocks Down Pre-Bell as Investors Parse Fed Chair Powell's Comments; Asia, Europe Rise	12-05	MT
Mizuho Initiates Veeva Systems at Outperform With $275 Price Target	12-04	MT
Veeva Systems Announces Vault CRM Bot and Vault CRM Voice Control, Two New GenAI Capabilities in Vault CRM	11-24	CI
Scotiabank Initiates Veeva Systems at Sector Perform	11-19	MT
Boehringer Ingelheim Commits to Veeva Vault CRM	11-14	CI
Veeva Systems Insider Sold Shares Worth $270,252, According to a Recent SEC Filing	11-12	MT
UBS Adjusts Price Target on Veeva Systems to $245 From $215, Maintains Neutral Rating	11-08	MT
RBC Adjusts Veeva Systems' Price Target to $275 From $250, Keeps Outperform Rating	11-08	MT

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Companyâs three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

Employees

7,172

Sector

Advanced Medical Equipment & Technology

Calendar

2025-03-03 - Q4 2025 Earnings Release (Projected)

More about the company